Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trial
- Author(s)
- Glewis, S; Alexander, M; Lingaratnam, S; Lee, B; Campbell, I; Krishnasamy, M; IJzerman, M; Fagery, M; Harris, S; Georgiou, C; Underhill, C; Warren, M; Campbell, R; Martin, J; Tie, J; Michael, M;
- Details
- Publication Year 2022-09,Volume 61,Issue #9,Page 1136-1139
- Journal Title
- Acta Oncologica
- Publication Type
- Research article
- Keywords
- Humans; *Heterocyclic Compounds/therapeutic use; Immunologic Factors/therapeutic use; Irinotecan; Multicenter Studies as Topic; *Neoplasms/drug therapy/genetics; Pharmacogenetics/methods
- Department(s)
- Pharmacy; Laboratory Research; Academic Nursing; Health Services Research; Medical Oncology
- PubMed ID
- 35972781
- Publisher's Version
- https://doi.org/10.1080/0284186X.2022.2109423
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-10-31 04:55:07
Last Modified: 2024-10-31 04:56:11